Can a nonviolent communication program help adults with schizophrenia communicate more effectively?

ISRCTN ISRCTN18284927
DOI https://doi.org/10.1186/ISRCTN18284927
Sponsor Chungnam National University
Funder Investigator initiated and funded
Submission date
18/11/2026
Registration date
18/11/2026
Last edited
18/11/2026
Recruitment status
No longer recruiting
Overall study status
Ongoing
Condition category
Mental and Behavioural Disorders
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Background and study aims
Some people with schizophrenia find it hard to express what they need or to talk through disagreements. This study asks whether adding group communication training to usual care helps adults with schizophrenia communicate more effectively. It also looks at changes in pulse measurements relating to stress and in psychiatric symptoms.

Who can participate?
Patients aged 19 to 64 years who had a diagnosis of schizophrenia and were receiving care at one of two psychiatric hospitals or two community mental health centres in South Korea. They needed to have taken their prescribed antipsychotic medication consistently for 3 months and to be able to read and answer a questionnaire themselves.

What does the study involve?
Each hospital or centre was assigned by chance to one of two groups. Everyone continued their usual care. People at the two training sites were offered ten 1-hour group sessions. They practised describing what happened, talking about feelings and needs, making requests, and listening to others. At three visits, participants are asked to complete a communication questionnaire, speak with a trained assessor and wear a clip on one earlobe for a 1-minute pulse recording. The visits take place before training, just after it ends and 4 weeks later.

What are the possible benefits and risks of participating?
The group sessions offer practice in expressing feelings and needs and in listening to other people. How much this helps is uncertain. Talking about personal experiences may feel uncomfortable. The ear clip may cause brief discomfort. Participants can take a break or stop taking part at any time. Their usual care continues.

Where is the study run from?
Chungnam National University (South Korea)

When is the study starting and how long is it expected to run for?
August 2026 to November 2026

Who is funding the study?
Investigator initiated and funded

Who is the main contact?
Hong gyu Park, hgdear@gmail.com

Contact information

Prof Moonhee Gang
Principal investigator

College of Nursing, Chungnam National University, 266 Munhwa-ro, Jung-gu
Daejeon
35015
Korea, South

Phone +82 (0)42 580 8332
Email mhgang@cnu.ac.kr
Mr Hong gyu Park
Scientific, Public

College of Nursing, Chungnam National University, 266 Munhwa-ro, Jung-gu
Daejeon
35015
Korea, South

Phone +82 (0)10 7632 0524
Email hgdear@gmail.com

Study information

Primary study designInterventional
AllocationRandomized controlled trial
MaskingBlinded (masking used)
ControlActive
AssignmentParallel
PurposeTreatment
Scientific titleA cluster-randomised controlled trial of nonviolent communication program for communication skills, stress and psychiatric symptoms in adults with schizophrenia
Study objectives To assess whether adding a nonviolent communication programme to usual care improves communication skills in adults with schizophrenia compared with usual care alone.

Secondary objectives are to assess changes in physiological measures related to stress and in psychiatric symptom severity.
Ethics approval(s)

Approved 02/06/2026, Chungnam National University Institutional Review Board (Room 301, Administration Building Annex (E7-1), Chungnam National University, 99 Daehak-ro, Yuseong-gu, Daejeon, 34134, Korea, South; +82 (0)42 821 5293; irb@cnu.ac.kr), ref: 202511-SB-228-01

Health condition(s) or problem(s) studiedSchizophrenia
InterventionThe institution was the unit of randomisation. Sealed Envelope’s online randomisation tool (https://www.sealedenvelope.com/) was used to randomise the four participating institutions. Randomisation was stratified by institution type. The two psychiatric hospitals formed one stratum, and the two community mental health welfare centres formed the other. Within each stratum, one institution was allocated to the nonviolent communication program plus usual care and the other to usual care alone. Individual participants were subsequently recruited into the study arm assigned to their institution.

The intervention arm received a group nonviolent communication programme in addition to usual care. Ten 60-minute sessions were delivered between 18 August and 27 October 2026. The programme manual uses discussion, paired practice and role-play to teach participants to describe observations, express feelings, identify needs, make requests and listen to others with empathy.

The control arm continued the usual care provided by its institution during the study.

Both arms followed the same assessment schedule. Outcome assessors were blinded to group allocation. Participants and intervention providers knew the allocation.
Intervention typeBehavioural
Primary outcome measure(s)
  1. Communication skills measured using the total score on a 30-item Korean self-report communication skills scale. Each item is rated from 1 to 5. Total scores range from 30 to 150, with higher scores indicating better communication skills. Measured at baseline (before the intervention), immediately after the intervention, and 4 weeks after the intervention.
Key secondary outcome measure(s)
  1. Device-reported heart rate variability index (HRV index) measured using a 1-minute optical pulse recording at the earlobe using the OMNIFIT MINDCARE system at baseline (before the intervention), immediately after the intervention (after 10 weeks), and 4 weeks after the intervention.
  2. Stress resistance standard deviation of normal-to-normal intervals (SDNN), in milliseconds, measured using a 1-minute earlobe pulse recording using OMNIFIT MINDCARE at baseline (before the intervention), immediately after the intervention, and 4 weeks after the intervention.
  3. Low-frequency to high-frequency power ratio (LF/HF ratio) measured using a 1-minute earlobe pulse recording using OMNIFIT MINDCARE at baseline (before the intervention), immediately after the intervention, and 4 weeks after the intervention.
  4. Psychiatric symptom severity measured using the total score on the 18-item Brief Psychiatric Rating Scale (BPRS), assessed by interview and observation. Each item is rated from 0 to 6. Total scores range from 0 to 108, with higher scores indicating more severe symptoms. Measured at baseline (before the intervention), immediately after the intervention, and 4 weeks after the intervention.
Completion date24/11/2026

Eligibility

Participant type(s)
Age groupAdult
Lower age limit19 Years
Upper age limit64 Years
SexAll
Target sample size at registration36
Total final enrolment36
Key inclusion criteria1. Aged 19 to 64 years and either admitted to a psychiatric ward at a participating hospital or registered with a participating community mental health welfare centre
2. Schizophrenia diagnosed by a psychiatrist according to Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) criteria
3. Stable use of prescribed antipsychotic medication for the preceding 3 months, as confirmed by the treating physician.
4. Able to communicate and to read and answer the questionnaire independently
5. Voluntary written informed consent from the participant, with written consent from the representative specified in the protocol
Key exclusion criteria1. Comorbid intellectual disability or an organic mental disorder
2. Unstable symptoms that impeded group participation. This criterion required at least one of the following in the preceding 2 weeks
2.1. Close observation for a high risk of harm to self or others, as judged by the treating physician
2.2. Documented severe agitation or aggression requiring seclusion, restraint or emergency intervention
2.3. Acute psychotic deterioration with a Brief Psychiatric Rating Scale score of 6 or higher on hallucinatory behaviour or unusual thought content
2.4. Delirium, disorientation, severe thought disorganisation, catatonia, substance intoxication or withdrawal that prevented communication or group participation, as judged by the physician or documented in the clinical record
3. Diagnosed hypertension or cardiovascular disease that could affect heart rate variability, with related treatment or medication within the preceding 6 months
Date of first enrolment14/08/2026
Date of final enrolment14/08/2026

Locations

Countries of recruitment

  • Korea, South

Study participating centres

Results and Publications

Individual participant data (IPD) Intention to shareYes
IPD sharing planResearchers may request anonymised participant-level data underlying the published findings from Professor Moonhee Gang (mhgang@cnu.ac.kr). Each request will be considered individually. Data may be released only after the required written consent for third-party sharing and ethics review have been obtained.

Editorial Notes

18/11/2026: Study's existence confirmed by the Chungnam National University Institutional Review Board.